Leading biotech research company expanding in Pécs

FOSS quadruplicates their number of employees in Hungary by adding 100 new, high value-added R&D jobs to the existing 30 positions. Moreover, Soft Flow, the subsidiary of the Danish biotechnology company is building a 2000 square meters, complex, Scandinavian-style office.

The new building will include everything needed, from offices, meeting rooms, SW development, R&D laboratories, facilities for simulations, mechanical engineering to reagent production with necessary Service- and Quality Control laboratories allowing for release and distribution of goods. The building expected to be completed until December 2019. The Hungarian Investment Promotion Agency (HIPA) assisted the EUR 6.3 million project with comprehensive project management services.

FOSS creates end-to-end solutions that secure and improve food quality, from raw material to finished product. Their analysis instruments refine measurements into information management that enables businesses to run intelligent data-driven productions with less waste and bigger yields. The family-owned Danish company, founded in 1956, is headquartered in Hillerød, Denmark, while development and production takes place in Denmark, China and Hungary. 80% of the grain, and 85% of the milk marketed globally is tested by products of the Danish company. FOSS, employing more than 14,000 highly qualified employees worldwide, has products marketed and sold through a global network in 30 countries.

The Hungarian subsidiary of FOSS, Soft Flow Hungary grew into an international recognized R&D company in the past and today employs more than 30 talented people working with biotechnology, research and assay development with bioanalytical services. The Pécs unit in southern Hungary is with strategic importance, because they produce chemical elements that are the 'soul' of the most innovative FOSS products.

“One key reason for us to expand in Pécs is the very good and long-term cooperation with the university that Soft Flow has. Knowledge is of outmost importance to us and the very key to unlock the potentials in Biotech,” FOSS Senior Vice President R&D, Niels Degn said.